Organized by top academic experts in lung cancer and thoracic malignancies, this is THE thoracic CME Conference that you should attend: Lung cancer specialists from a wide range of disciplines will share information on the latest developments in basic, clinical and translational research. Learning objectives: To analyze and interpret effectively the increasing amount of new clinical data available for multidisciplinary treatment decisions in patients with lung cancer and other thoracic malignancies. To determine the optimal roles of new diagnostics and therapeutics in clinical scenarios for the treatment of patients with early, locally-advanced and metastatic disease. To evaluate the roles of biological markers, specific gene mutations and pathological determinants in the development of optimal treatment strategies for systemic therapy of lung cancer patients. This course has been listed as one of the deliverables from the EU FP7-funded EurocanPlatform project. For information on EurocanPlatform visit: http://www.eurocanplatform.eu